The Stanford Cancer Institute (SCI) is a distinguished National Cancer Institute (NCI)-designated Comprehensive Cancer Center, integral to Stanford Medicine and Stanford University. It unites a diverse team of world-class researchers, physicians, and healthcare professionals dedicated to pioneering cancer research, translating discoveries into effective therapies, and providing exceptional, patient-centered care. The SCI is at the forefront of developing novel prevention strategies, diagnostic tools, and treatments for all types of cancer, offering patients access to cutting-edge clinical trials and a multidisciplinary approach to their health journey.
Serves as the primary hub for advanced patient care, innovative cancer research, clinical trials, education, and administrative operations of the Institute.
State-of-the-art clinical facilities, advanced radiation oncology, infusion centers, connection to Stanford Hospital, integrated research laboratories, and patient support services.
A highly collaborative, intellectually stimulating, and patient-centric environment. Emphasizes multidisciplinary teamwork, continuous learning, innovation, and a compassionate approach to care and research.
As one of the elite NCI-designated Comprehensive Cancer Centers, it is a leading institution nationally and internationally for pioneering cancer research, developing novel therapies, and training the next generation of cancer specialists.
While its primary clinical operations are based in Northern California, the Stanford Cancer Institute exerts a significant global influence through international research collaborations, participation in global clinical trials, training programs for physicians and scientists from around the world, and the widespread dissemination of its research findings. Its faculty are often involved in shaping international cancer treatment guidelines and advancing cancer knowledge globally.
875 Blake Wilbur Drive
Stanford
CA
USA
Address: 2589 Samaritan Dr, San Jose, CA 95124
To extend Stanford's advanced cancer treatment capabilities and clinical trial access to the communities in and around San Jose and the broader South Bay area.
Address: 5800 Hollis St, Emeryville, CA 94608
To provide convenient access to Stanford's high-quality cancer care for patients residing in the East Bay, reducing travel time for regular treatments and consultations.
Address: 420 Broadway St, Redwood City, CA 94063
To enhance accessibility of specialized outpatient cancer services for residents of the Peninsula and surrounding areas.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Stanford Cancer Institute' leadership includes:
Stanford Cancer Institute has been backed by several prominent investors over the years, including:
Major leadership roles at the Stanford Cancer Institute, such as the Director and Deputy Director, have been stable. Any significant changes are typically announced via Stanford Medicine official channels. Minor changes in associate director roles or program leaders may occur periodically.
Discover the tools Stanford Cancer Institute uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Email addresses at Stanford University, including those for Stanford Cancer Institute personnel, primarily use the '@stanford.edu' domain. Formats typically involve the individual's SUNet ID (Stanford University Network ID) or a combination of their first and last name.
[sunetid]@stanford.edu or [firstinitial][lastname]@stanford.edu or [firstname].[lastname]@stanford.edu
Format
jdoe@stanford.edu
Example
90%
Success rate
Stanford Medicine News Center • May 28, 2024
A study by Stanford Medicine researchers, including members of the Stanford Cancer Institute, identified a protein called GPS2 whose inhibition could be a new therapeutic strategy for acute myeloid leukemia (AML). Blocking GPS2 killed AML cells while sparing healthy blood cells in lab tests....more
Stanford Medicine News Center • April 18, 2024
Stanford Cancer Institute researchers found that a specific type of radiation therapy (FLASH) combined with immunotherapy can overcome resistance to cancer treatment in mouse models. The study suggests this approach could make previously unresponsive tumors susceptible to immunotherapy....more
Stanford Medicine Scope Blog • February 20, 2024
Dr. Lidia Schapira, Associate Director for Cancer Care Delivery at the Stanford Cancer Institute, commented on the updated U.S. Preventive Services Task Force lung cancer screening guidelines, highlighting their potential to detect more cancers earlier and save lives by expanding eligibility....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Stanford Cancer Institute, are just a search away.